Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia

BACKGROUND: Ischemic heart disease is the leading cause of death in the world and is associated with dyslipidemia, high blood pressure, diabetes mellitus, and other factors. OBJECTIVE: To determine the clinical effectiveness on the lipid profile of the rosuvastatin + fenofibric acid combination in C...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado-Duque, Manuel E., Gaviria-Mendoza, Andrés, Machado-Alba, Jorge E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Latin America Health: Public Policy and Primary Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705806/
https://www.ncbi.nlm.nih.gov/pubmed/33251941
http://dx.doi.org/10.1177/2150132720977733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705806/
https://www.ncbi.nlm.nih.gov/pubmed/33251941
http://dx.doi.org/10.1177/2150132720977733

Ejemplares similares